Insmed inc (INSM)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
License fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,002

253

0

0

0

-

Other revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other expanded access program income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,415

4,568

5,998

0

0

0

Revenues, net

151,425

136,467

100,594

61,709

31,737

9,835

0

0

0

0

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,417

4,821

6,250

0

0

0

Cost of product revenues (excluding amortization of intangible assets)

28,500

24,212

17,929

11,492

6,573

2,423

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gross profit

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

136,692

131,711

139,006

144,204

146,388

145,283

139,307

126,444

117,593

109,749

130,670

127,428

124,428

122,721

87,497

83,285

77,660

74,277

69,430

65,409

62,105

56,292

51,118

48,013

45,296

44,279

46,245

39,856

35,376

29,781

25,414

26,641

27,602

28,623

22,168

16,128

0

0

0

Selling, general and administrative

207,332

210,796

214,550

205,648

190,375

168,218

145,662

118,625

98,109

79,171

59,948

56,256

51,874

50,679

51,442

48,750

46,194

43,216

38,539

35,719

33,887

31,073

28,776

25,319

24,989

22,236

20,513

19,413

14,107

12,657

11,460

10,285

10,792

11,523

10,109

9,521

0

0

0

Amortization of intangible assets

4,994

4,993

4,994

3,745

2,497

1,249

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and expenses

349,018

347,500

369,906

358,516

339,260

314,750

284,969

245,069

215,702

188,920

190,618

183,684

176,302

173,400

138,939

132,035

123,854

117,493

107,969

101,128

95,992

87,365

79,894

73,332

70,285

66,515

66,758

59,269

49,483

42,438

36,874

62,916

64,384

66,136

58,267

25,649

0

0

0

Impairment loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

Operating loss

-226,093

-235,245

-275,885

-303,380

-314,096

-307,338

-284,969

-245,069

-215,702

-188,920

-190,618

-183,684

-176,302

-173,400

-138,939

-132,035

-123,854

-117,493

-107,969

-101,128

-95,992

-87,365

-79,894

-73,332

-58,785

-55,015

-55,258

-47,769

-49,483

-42,438

-35,471

-61,078

-61,568

-61,719

-53,446

-19,399

0

0

0

Investment income

8,909

9,921

10,710

10,566

10,717

10,341

8,485

6,070

3,510

1,624

781

593

588

604

567

504

408

261

183

120

64

58

66

94

132

166

1,062

1,215

1,455

1,822

1,608

1,786

1,955

2,064

1,702

1,869

0

0

0

Interest expense

28,390

27,705

27,024

26,853

26,556

25,472

20,271

15,092

10,093

5,925

5,942

5,215

4,350

3,498

2,739

2,695

2,789

2,889

2,785

2,654

2,531

2,415

2,404

2,335

2,375

2,412

2,341

2,038

1,404

763

226

6

8

10

9

7

0

0

0

Loss on extinguishment of debt

-

-

-9

-9

-

-2,209

-2,200

-2,200

-2,200

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-376

-531

-203

102

397

602

644

525

481

300

233

177

9

119

95

-17

-54

-33

-47

16

196

141

117

121

-54

-33

0

0

0

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-245,950

-253,560

-292,402

-319,565

-329,538

-324,076

-298,320

-255,775

-224,013

-192,921

-195,546

-188,129

-180,055

-176,175

-141,016

-134,243

-126,289

-120,154

-110,618

-103,646

-98,263

-89,581

-82,115

-75,452

-61,082

-57,294

-56,535

-48,590

-49,430

-41,374

-34,083

-59,292

-59,615

-59,664

-51,753

-17,537

0

0

0

Gain on sale of assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

Provision for income taxes

577

777

601

501

401

201

-366

-339

-302

-272

121

119

100

98

0

0

0

-

-

-

-

-10,422

-4,389

-4,389

-4,389

-1,221

-1,225

-1,225

-1,223

0

2

2

0

0

79

82

0

0

0

Net loss

-246,548

-254,337

-292,922

-319,983

-329,906

-324,277

-298,088

-255,524

-223,759

-192,649

-195,667

-188,248

-180,155

-176,273

-139,116

-132,318

-124,346

-118,183

-104,585

-97,613

-92,230

-79,159

0

0

0

-

-

-

-

-

-

-

-

-59,664

-51,832

-17,619

0

0

0

Basic and diluted net loss per share (in dollars per share)

-0.74

-0.56

-0.68

-0.81

-0.96

-1.19

-1.14

-1.00

-0.89

-0.88

-0.69

-0.72

-0.60

-1.11

-0.61

-0.59

-0.54

-0.50

-0.50

-0.47

-0.55

-0.35

-0.54

-0.59

-0.36

-0.43

-0.46

-0.28

-0.43

-0.51

-0.38

-0.39

-0.28

-0.31

-1.39

-0.40

-0.85

-0.03

-0.03

Weighted average basic and diluted common shares outstanding

89,779

89,648

89,245

81,806

77,541

77,104

77,066

76,767

76,619

76,742

65,312

62,209

62,041

61,954

61,878

61,878

61,858

61,968

61,774

60,833

49,957

49,785

44,082

39,273

39,240

39,223

37,389

31,754

31,554

31,432

25,013

24,875

24,860

49,720

24,833

24

18,814

13,030

13,025

Accretion of beneficial conversion charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,175

-9,175

-9,175

0

0

0

Net loss

-246,548

-254,337

-292,922

-319,983

-329,906

-324,277

0

0

0

-

-

-

-180,155

-176,273

-139,116

-132,318

-124,346

-118,183

0

0

0

-

-

-

-

-

-

-

-

-41,374

-34,085

-59,294

-59,615

-68,839

-61,007

-26,794

0

0

0

Other comprehensive income (loss):
Foreign currency translation (losses) gains

-77

-1

-28

-25

-9

-6

-14

60

86

62

39

-54

-44

-65

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-246,548

-254,337

-292,922

-319,983

-329,906

-324,277

0

0

0

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-34,085

-59,294

-59,615

-68,839

-61,007

-26,794

0

0

0

Unrealized loss on investments, net of taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-450

0

0

0

-

-

-

-

-

-

Total comprehensive loss

-246,625

-254,338

-292,950

-320,008

-329,915

-324,283

-298,102

-255,464

-223,673

-192,587

-195,628

-188,302

-180,199

-176,338

-139,121

-132,306

-124,349

-118,183

0

0

0

-

-

-

-

-

-56,145

-48,001

-48,873

-41,824

-43,296

-68,950

-68,938

-69,382

0

0

0

-

-

Weighted average diluted common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,025